Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
absorb, Adelaide, admitted, arbitration, ATM, box, bronchospasm, Catalyst, clarified, cocaine, Colorado, compel, concomitant, confusion, contraindication, diplomatic, display, Endo, expert, exploring, faith, finite, frequently, GAAP, GDNF, immigration, instability, internationally, intravenously, irrespective, McNicoll, MIF, mirabegron, mitoxantrone, MLV, MOH, OCI, ombrabulin, overuse, pari, passu, perception, PinatosR, Pound, PTO, qualitative, rarely, reclassification, renegotiate, residence, retosiban, Sabril, shelf, Shering, someday, specialist, staffed, staffing, standstill, Street, tandem, tangible, Tractocile, traveling, typify, UCLA, unrest, USA, USPTO, Vigabatrin, Vlak, Wall, wheezing, wording, wrote, ZYBRESTAT
Removed:
acetate, achieving, added, adjust, Aggregated, America, appeal, Attorney, attributed, automatic, Avonex, beclomethasone, beta, broadly, bronchodilator, careful, carryforward, classification, Copaxone, Dutch, earning, EITF, eosinophil, euro, exempt, fact, Flovent, fluticasone, glatiramer, hedging, Ib, injection, lapse, laquinimod, linkage, liquidated, location, marketable, masilukast, maximizing, MCC, natalizumab, neurodegenerative, North, offered, organizational, outlook, passed, practicable, predetermined, project, ratified, readily, Rebif, reclassified, recoverable, regularly, rendered, responsive, revaluation, Schering, Schwarz, sublicensable, sublicenseable, suplatast, supported, Taiho, teriflunomide, tosilate, twelve, Tysabri, underdiagnosed, undergoing, underserved, Vanceril, York, ZBRESTAT
Filing tables
Filing exhibits
- 10-K Annual report
- 10.2 Amended and Restated 2004 Stock Incentive Plan of the Registrant
- 23.1 Consent of Independent Registered Public Accounting Firm
- 23.2 Consent of Independent Registered Public Accounting Firm
- 31.1 Certification of the Chief Executive Officer
- 31.2 Certification of the Chief Financial Officer
- 32.1 Certification of the Chief Executive Officer
- 32.2 Certification of the Chief Financial Officer
Related press release
MNOV similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-151808, 333-141694 and 333-122665) and Form S-3 (No. 333-163116) of MediciNova, Inc. and in the related Prospectus of our reports dated March 28, 2012, with respect to the consolidated financial statements of MediciNova, Inc., and the effectiveness of internal control over financial reporting of MediciNova, Inc., included in this Annual Report (Form 10-K) for the year ended December 31, 2011.
/s/ Ernst & Young LLP
San Diego, California
March 28, 2012